To see the other types of publications on this topic, follow the link: Proliferative vitreoretinopath.

Journal articles on the topic 'Proliferative vitreoretinopath'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Proliferative vitreoretinopath.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Lewis, Hilel, Janice M. Burke, Gary W. Abrams, and Thomas M. Aaberg. "Perisilicone Proliferation after Vitrectomy for Proliferative Vitreoretinopathy." Ophthalmology 95, no. 5 (May 1988): 583–91. http://dx.doi.org/10.1016/s0161-6420(88)33136-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hatchell, D. L., T. McAdoo, S. Sheta, R. T. King, and J. V. Bartolome. "Quantification of Cellular Proliferation in Experimental Proliferative Vitreoretinopathy." Archives of Ophthalmology 106, no. 5 (May 1, 1988): 669–72. http://dx.doi.org/10.1001/archopht.1988.01060130731033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

NAQVI, SYED ABID HASSAN, SOHAIL SHEHZAD, and OMAR ZAFAR. "PROLIFERATIVE VITREORETINOPATHY." Professional Medical Journal 13, no. 01 (March 6, 2006): 42–46. http://dx.doi.org/10.29309/tpmj/2006.13.01.5055.

Full text
Abstract:
Objective: The objective of study to assess the success of pars planavitrectomy with use of silicone Oil for internal tamponade in traumatic rhegmatogenous R D with severe PVR. Setting& Period: This study was carried out in department of Ophthalmology Military Hospital Rawalpindi. Material &Methods: Fifteen cases with severe proliferative vitreoretinopathy (PVR Grade C, according to up dated retina SocietyClassification of 1991) was included in study. All the patients had traumatic rhegmatogenous retinal detachment withhistory of blunt ocular trauma, without globe rupture, outcome of the treatment was assessed by post operativeanatomical and physiological success. Results: Anatomical success was encouraging in-spite of advance disease andtechnically difficult and complicated intra-ocular maneuvers.
APA, Harvard, Vancouver, ISO, and other styles
4

Chaum, Edward. "Proliferative Vitreoretinopathy." International Ophthalmology Clinics 35, no. 1 (1995): 163–73. http://dx.doi.org/10.1097/00004397-199503510-00017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

WILKES, SHELBY R., AHMAD M. MANSOUR, and W. RICHARD GREEN. "PROLIFERATIVE VITREORETINOPATHY." Retina 7, no. 2 (1987): 94–101. http://dx.doi.org/10.1097/00006982-198700720-00007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

SCHWARTZ, DANIEL, ZENAIDA C. DE LA CRUZ, RICHARD W. GREEN, and RONALD G. MICHELS. "PROLIFERATIVE VITREORETINOPATHY." Retina 8, no. 4 (1988): 275–81. http://dx.doi.org/10.1097/00006982-198808040-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Blumenkranz, Mark S. "Proliferative Vitreoretinopathy." Retina 12, no. 1 (1992): 70. http://dx.doi.org/10.1097/00006982-199212010-00014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wiedemann, Peter, and Klaus Heimann. "Proliferative vitreoretinopathy." Current Opinion in Ophthalmology 3, no. 3 (June 1992): 357–65. http://dx.doi.org/10.1097/00055735-199206000-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Coffee, Robert E., Lai Jiang, and Salman A. Rahman. "Proliferative Vitreoretinopathy." International Ophthalmology Clinics 54, no. 2 (2014): 91–109. http://dx.doi.org/10.1097/iio.0000000000000023.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Idrees, Sana, Jayanth Sridhar, and Ajay E. Kuriyan. "Proliferative Vitreoretinopathy." International Ophthalmology Clinics 59, no. 1 (2019): 221–40. http://dx.doi.org/10.1097/iio.0000000000000258.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Charteris, David G., Paul Hiscott, Ian Grierson, and Susan L. Lightman. "Proliferative Vitreoretinopathy." Ophthalmology 99, no. 9 (September 1992): 1364–67. http://dx.doi.org/10.1016/s0161-6420(92)31793-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Schwartz, Steven D., and Allan E. Kreiger. "Proliferative vitreoretinopathy." Ophthalmology 105, no. 5 (May 1998): 785–88. http://dx.doi.org/10.1016/s0161-6420(98)95015-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Leaver, P. K. "Proliferative vitreoretinopathy." British Journal of Ophthalmology 79, no. 10 (October 1, 1995): 871–72. http://dx.doi.org/10.1136/bjo.79.10.871.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Tennant, Matthew T. S., Mark L. Nelson, Kent A. Blade, Sunir J. Garg, and Richard G. Lane. "Proliferative Vitreoretinopathy." Ophthalmology 114, no. 9 (September 2007): 1793–94. http://dx.doi.org/10.1016/j.ophtha.2007.03.044.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Barile, Gaetano, Stanley Chang, and William Schiff. "Proliferative Vitreoretinopathy." Ophthalmology 114, no. 9 (September 2007): 1794. http://dx.doi.org/10.1016/j.ophtha.2007.04.028.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Pastor, J. Carlos. "Proliferative Vitreoretinopathy." Survey of Ophthalmology 43, no. 1 (July 1998): 3–18. http://dx.doi.org/10.1016/s0039-6257(98)00023-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Park, Young Hoon, Bong Hwan Lee, and Duk Kee Hahn. "Experimental proliferative vitreoretinopathy." Yeungnam University Journal of Medicine 8, no. 1 (1991): 178. http://dx.doi.org/10.12701/yujm.1991.8.1.178.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Jerdan, Janice A., Jay S. Pepose, Ronald G. Michels, Hideyuki Hayashi, Serge De Bustros, Mikael Sebag, and Bert M. Glaser. "Proliferative Vitreoretinopathy Membranes." Ophthalmology 96, no. 6 (June 1989): 801–10. http://dx.doi.org/10.1016/s0161-6420(89)32818-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Lewis, Hilel, and Thomas M. Aaberg. "Anterior Proliferative Vitreoretinopathy." American Journal of Ophthalmology 105, no. 3 (March 1988): 277–84. http://dx.doi.org/10.1016/0002-9394(88)90010-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Gregor, Z. J. "Proliferative Vitreoretinopathy (PVR)." British Journal of Ophthalmology 74, no. 4 (April 1, 1990): 255. http://dx.doi.org/10.1136/bjo.74.4.255.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Jin, Ying, Huijin Chen, Xiaojian Xu, Yuntao Hu, Changguan Wang, and Zhizhong Ma. "TRAUMATIC PROLIFERATIVE VITREORETINOPATHY." Retina 37, no. 7 (July 2017): 1236–45. http://dx.doi.org/10.1097/iae.0000000000001350.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Wiedemann, P., and A. Bringmann. "Die proliferative Vitreoretinopathie." Klinische Monatsblätter für Augenheilkunde 233, no. 09 (August 1, 2016): 1012–15. http://dx.doi.org/10.1055/s-0042-109704.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Kruger, Erik F., Quan Dong Nguyen, Meisy Ramos-Lopez, and Kameran Lashkari. "Proliferative Vitreoretinopathy After Trauma." International Ophthalmology Clinics 42, no. 3 (2002): 129–43. http://dx.doi.org/10.1097/00004397-200207000-00015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Cardillo, Jose A., J. Timothy Stout, Laurie LaBree, Stanley P. Azen, Luis Omphroy, Jing Z. Cui, Hideya Kimura, David R. Hinton, and Stephen J. Ryan. "Post-traumatic Proliferative Vitreoretinopathy." Ophthalmology 104, no. 7 (July 1997): 1166–73. http://dx.doi.org/10.1016/s0161-6420(97)30167-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

El Ghrably, I. "Apoptosis in Proliferative Vitreoretinopathy." Investigative Ophthalmology & Visual Science 45, no. 5 (May 1, 2004): 1473–79. http://dx.doi.org/10.1167/iovs.03-0060.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

KIM, I., and J. ARROYO. "Mechanisms in proliferative vitreoretinopathy." Ophthalmology Clinics of North America 15, no. 1 (March 2002): 81–86. http://dx.doi.org/10.1016/s0896-1549(01)00008-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Limb, G. A., B. C. Little, A. Meager, J. A. Ogilvie, R. A. Wolstencroft, W. A. Franks, A. H. Chignell, and D. C. Dumonde. "Cytokines in proliferative vitreoretinopathy." Eye 5, no. 6 (November 1991): 686–93. http://dx.doi.org/10.1038/eye.1991.126.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Baudouin, Ch, Fr Brignole, D. Fredj-Reygrobellet, Ph Lapalus, and P. Gastaud. "Class II antigen expression by proliferating RPE cells in proliferative vitreoretinopathy." Experimental Eye Research 55 (September 1992): 139. http://dx.doi.org/10.1016/0014-4835(92)90696-p.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Yang, Chung-May, Karl R. Olsen, Eleut Hernandez, and Scott W. Cousins. "Measurement of cellular proliferation within the vitreous during experimental proliferative vitreoretinopathy." Graefe's Archive for Clinical and Experimental Ophthalmology 230, no. 1 (January 1992): 66–71. http://dx.doi.org/10.1007/bf00166765.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Resch, Miklós, and Anikó Balogh. "Proliferatív vitreoretinopathia." Szemészet 159, no. 2 (2022): 51–61. http://dx.doi.org/10.55342/szemhungarica.2022.159.2.51.

Full text
Abstract:
A proliferatív vitreoretinopathia (PVR) egy kóros állapot, amelyhez számos vitreoretinális kórkép, elsődlegesen a retinaleválás vezet. Az egyre bővülő molekuláris biológiai tudás, az arra épített farmakológiai fejlesztések ellenére jelenleg is elsődlegesen sebészi úton ellátandó betegség, amelynek számos kockázati tényezője van. Komplexitásában nézve a műtéti technika és vizualizáció nagyléptékű fejlődése mellett sem sikerült megszüntetni ezt a látást veszélyeztető kórképet és továbbra is jelentős kihívást jelent a jelenlegi és jövőbeli vitreoretinális sebészek és általános szemészek számára egyaránt. Jelen továbbképző közlemény célja a tudomány állásának naprakész eredményeit bemutatni.
APA, Harvard, Vancouver, ISO, and other styles
31

Krupina, E. A., O. A. Pavlovsky, and E. A. Larina. "Subretinal proliferation. What to do?" Modern technologies in ophtalmology, no. 3 (July 15, 2021): 90–93. http://dx.doi.org/10.25276/2312-4911-2021-3-90-93.

Full text
Abstract:
Purpose. Evaluation of treatment results retinal detachment complicated by subretinal PVR. Materials and methods. We examined 13 patients (13 eyes) with operated retinal detachment (RD), subretinal proliferative vitreoretinopathy (PVR). In the main group (7 eyes) with recurrence of retinal detachment RD was complicated by severe subretinal proliferation. Аll the patients underwent surgical treatment of retinal detachment with removal of the subretinal PVR; in the control group (6 eyes) subretinal proliferation was localized in the zone of the adjacent retina and its removal was not performed. Results. The compared groups did not differ in terms of age and gender, the axis length of the eye. Duration of the RD was more than 3 months. During the observation period of 6 months of patients both groups, in all cases, it was possible to achieve a fit of the retina. Conclusion. 1. Subretinal PVR should be removed when it is localized in the macular area, or when it leads to retinal detachment, preventing it from fitting with standard technical manipulations. 2. Potential of microinvasive vitreoretinal surgery allow to effectively eliminate subretinal PVR, complementing standard manipulations, with a good functional and anatomical result. Keywords: retinal detachment, proliferative vitreoretinopathy, anatomical outcome.
APA, Harvard, Vancouver, ISO, and other styles
32

Schaub, F., P. Enders, and S. Fauser. "Proliferative Vitreoretinopathie: therapeutische Strategien." Klinische Monatsblätter für Augenheilkunde 233, no. 09 (August 1, 2016): 1016–23. http://dx.doi.org/10.1055/s-0042-107947.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Wu, Frances, and Dean Eliott. "Molecular Targets for Proliferative Vitreoretinopathy." Seminars in Ophthalmology 36, no. 4 (February 22, 2021): 218–23. http://dx.doi.org/10.1080/08820538.2021.1890791.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Sun, Jennifer K., and Jorge G. Arroyo. "Adjunctive Therapies for Proliferative Vitreoretinopathy." International Ophthalmology Clinics 44, no. 3 (2004): 1–10. http://dx.doi.org/10.1097/00004397-200404430-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Khan, Mohammed A., Christopher J. Brady, and Richard S. Kaiser. "CLINICAL MANAGEMENT OF PROLIFERATIVE VITREORETINOPATHY." Retina 35, no. 2 (February 2015): 165–75. http://dx.doi.org/10.1097/iae.0000000000000447.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Nagasaki, Hiroshi, and Kouichi Shinagawa. "Risk factors for proliferative vitreoretinopathy." Current Opinion in Ophthalmology 6, no. 3 (June 1995): 70–75. http://dx.doi.org/10.1097/00055735-199506000-00012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

JONAS, JB. "How to prevent proliferative vitreoretinopathy ?" Acta Ophthalmologica 90 (August 6, 2012): 0. http://dx.doi.org/10.1111/j.1755-3768.2012.1554.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Kubota, Toshiaki, Kasumi Kurihara, Tatsuro Ishibashi, and Hajime Inomata. "Proliferative Vitreoretinopathy in Coats’ Disease." Ophthalmologica 209, no. 1 (1995): 44–46. http://dx.doi.org/10.1159/000310576.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Baudouin, Christophe, Danielle Fredj-Reygrobellet, Françoise Baudouin, Philippe Lapalus, and Pierre Gastaud. "Immunohistologic Study of Proliferative Vitreoretinopathy." American Journal of Ophthalmology 108, no. 4 (October 1989): 387–94. http://dx.doi.org/10.1016/s0002-9394(14)73306-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Comaratta, Mark R., Stanley Chang, and Janet Sparrow. "Iris Neovascularizadon in Proliferative Vitreoretinopathy." Ophthalmology 99, no. 6 (June 1992): 898–905. http://dx.doi.org/10.1016/s0161-6420(92)31889-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Nagasaki, Hiroshi, Kouichi Shinagawa, and Manabu Mochizuki. "Risk factors for proliferative vitreoretinopathy." Progress in Retinal and Eye Research 17, no. 1 (January 1998): 77–98. http://dx.doi.org/10.1016/s1350-9462(97)00007-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Hwang, Cindy S., Pia R. Mendoza, Jill R. Wells, Hans E. Grossniklaus, and G. Baker Hubbard. "Proliferative Vitreoretinopathy in Treated Retinoblastoma." Ophthalmology Retina 1, no. 2 (March 2017): 165–72. http://dx.doi.org/10.1016/j.oret.2016.09.009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

CHARTERIS, D. G. "Growth factors in proliferative vitreoretinopathy." British Journal of Ophthalmology 82, no. 2 (February 1, 1998): 106. http://dx.doi.org/10.1136/bjo.82.2.106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Sakamoto, Taiji. "Animal Model of Proliferative Vitreoretinopathy." Japanese Journal of Pharmacology 82 (2000): 19. http://dx.doi.org/10.1016/s0021-5198(19)47554-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Danis, Ronald P., and Toichiro Kuwabara. "Proliferative Vitreoretinopathy in Fundus Flavimaculatus." American Journal of Ophthalmology 113, no. 6 (June 1992): 713–14. http://dx.doi.org/10.1016/s0002-9394(14)74801-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Asaria, Riaz Hassan Yusuf, Chee Hing Kon, Catey Bunce, David G. Charteris, David Wong, Philip J. Luthert, Peng Tee Khaw, and George William Aylward. "How to predict proliferative vitreoretinopathy." Ophthalmology 108, no. 7 (July 2001): 1184–86. http://dx.doi.org/10.1016/s0161-6420(01)00553-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Yoon, Young Doo, Thomas M. Aaberg, Ted H. Wojno, and Hans E. Grossniklaus. "Osseous metaplasia in proliferative vitreoretinopathy." American Journal of Ophthalmology 125, no. 4 (April 1998): 558–59. http://dx.doi.org/10.1016/s0002-9394(99)80201-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Radtke, N. D., A. D. Weinsieder, and R. J. Ballou. "Pharmacological therapy for proliferative vitreoretinopathy." Graefe's Archive for Clinical and Experimental Ophthalmology 224, no. 3 (May 1986): 230–33. http://dx.doi.org/10.1007/bf02143060.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

St�dtler, Michael, Holger Mietz, Peter Wiedemann, and Klaus Heimann. "Immunohistochemistry of anterior proliferative vitreoretinopathy." International Ophthalmology 18, no. 6 (1995): 323–28. http://dx.doi.org/10.1007/bf00930309.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Tan, H. Stevie, Marco Mura, Sarit Y. Lesnik Oberstein, and Marc D. de Smet. "Primary Retinectomy in Proliferative Vitreoretinopathy." American Journal of Ophthalmology 149, no. 3 (March 2010): 447–52. http://dx.doi.org/10.1016/j.ajo.2009.10.017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography